Single Fractions SBRT for Prostate Cancer

NARecruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

November 7, 2018

Primary Completion Date

January 31, 2027

Study Completion Date

December 20, 2027

Conditions
Prostate Cancer
Interventions
RADIATION

Stereotactic Body Radiation Therapy (SBRT)

Shorter radiation therapy means that a higher dose will be offered. To limit side effects of exposure to a high dose, a medical device protecting the rectum will be used. The medical device to be used is called SpaceOAR hydrogel (device). The SpaceOAR hydrogel creates space between the rectum and the prostate, making it much less likely that the rectum is exposed to radiation. It is injected into place prior to the start of radiation treatment using a needle. Patients may be awake or asleep under local anesthesia for the procedure. SpaceOAR hydrogel is not painful, it remains stable during radiation therapy and then is gradually absorbed by the body over the course of approximately six months, once radiation therapy has been completed.

Trial Locations (1)

H4A 3J1

RECRUITING

McGill University Health Centre-Cedars Cancer Centre, Montreal

Sponsors
All Listed Sponsors
collaborator

Boston Scientific Corporation

INDUSTRY

lead

Fabio Cury

OTHER